Koyfin Home > Directory > Health Care > Alexion Pharm Inc > Gross Margin

Alexion Pharm Inc Gross Margin Chart (ALXN)

Alexion Pharm Inc annual/quarterly Gross Margin from 2010 to 2020. Gross margin is a company's total sales revenue minus its cost of goods sold (COGS), divided by total sales revenue, expressed as a percentage. The higher the percentage, the more the company retains on each dollar of sales, to service its other costs and debt obligations.
  • Alexion Pharm Inc Gross Margin for the quarter ending September 09, 2020 was $91m a -0.94% decrease of -1m year over year
  • Alexion Pharm Inc Gross Margin for the last 12 months ending September 09, 2020 was $91m a -0.98% decrease of -1m year over year
  • Alexion Pharm Inc Annual Gross Margin for 2019 was $92m a 1.10% increase of 1m from 2018
  • Alexion Pharm Inc Annual Gross Margin for 2018 was $91m a -0.45% decrease of 0m from 2017
  • Alexion Pharm Inc Annual Gross Margin for 2017 was $91m a -0.14% decrease of 0m from 2016
Other Margins & Efficiency Metrics:
  • Alexion Pharm Inc EBITDA Margin for the quarter ending December 12, 2018 was $47m a 0.71% increase of 0m year over year
  • Alexion Pharm Inc Return on Capital % for the quarter ending December 12, 2018 was 8.64 a 20.76% increase of 1.79 year over year
  • Alexion Pharm Inc Return on Equity % for the quarter ending December 12, 2018 was -1.96 a 663.73% decrease of -13.03 year over year
View Chart On Koyfin

Quarterly ALXN Gross Margin Data

09/2020$91m
06/2020$90m
03/2020$92m
12/2019$92m
09/2019$92m
06/2019$92m
03/2019$92m
12/2018$91m
09/2018$91m
06/2018$91m

Annual ALXN Gross Margin Data

2019$92m
2018$91m
2017$91m
2016$92m
2015$91m
2014$92m
2013$89m
2012$89m
2011$88m
2010$88m